Connecticut 2017 Regular Session Status: In Committee

SB 552 — AN ACT CONCERNING A STANDING ORDER PROGRAM FOR DISPENSING OPIOID ANTAGONISTS.

Last action — MOVED TO FOOT OF CAL., SENATE

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2017 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

8 added · 14 removed

Plain-language change summary

The amendment changes the language regarding how a prescribing practitioner issues a standing order for an opioid antagonist to a pharmacist. Instead of stating that a practitioner may prescribe by standing order, the updated text clarifies that the practitioner may issue a standing order which enables pharmacists to dispense the medication. This distinction matters as it may facilitate the process for pharmacists to provide opioid antagonists to individuals at risk of overdose without needing a patient-specific prescription. Additionally, it specifies that pharmacists must be certified to dispense these medications under this order.

→
Previous
Latest
General Assembly   Committee Bill No.
General Assembly   Substitute Bill No.
552 January Session, 2017   LCO No.
552 January Session, 2017   *_____SB00552PH____032817____* AN ACT CONCERNING A STANDING ORDER PROGRAM FOR DISPENSING OPIOID ANTAGONISTS.
4430   *04430SB00552PH_* Referred to Committee on PUBLIC HEALTH   Introduced by:
  (PH)   AN ACT CONCERNING A STANDING ORDER PROGRAM FOR DISPENSING OPIOID ANTAGONISTS.
(NEW) (Effective October 1, 2017) (a) A prescribing practitioner, as defined in section 20-14c of the general statutes, who is authorized to prescribe an opioid antagonist, as defined in section 17a-714a of the general statutes, may prescribe, by standing order issued to a pharmacist licensed under part II of chapter 400j of the general statutes, an opioid antagonist that is (1) administered by an intranasal application delivery system or an auto-injection delivery system, (2) approved by the federal Food and Drug Administration, and (3) dispensed by a pharmacist to any person at risk of experiencing an overdose of an opioid drug, as defined in 42 CFR 8.2, or to a family member, friend or other person in a position to assist a person at risk of experiencing an overdose of an opioid drug.
(NEW) (Effective October 1, 2017) (a) A prescribing practitioner, as defined in section 20-14c of the general statutes, who is authorized to prescribe an opioid antagonist, as defined in section 17a-714a of the general statutes, may issue a standing order to a pharmacist licensed under part II of chapter 400j of the general statutes, enabling the pharmacist to dispense an opioid antagonist that is (1) administered by an intranasal application delivery system or an auto-injection delivery system, (2) approved by the federal Food and Drug Administration, and (3) dispensed by a pharmacist to any person at risk of experiencing an overdose of an opioid drug, as defined in 42 CFR 8.2, or to a family member, friend or other person in a position to assist a person at risk of experiencing an overdose of an opioid drug.
Any such prescription shall be deemed issued for a legitimate medical purpose in the usual course of the prescribing practitioner's professional practice.
Any such standing order shall be deemed issued for a legitimate medical purpose in the usual course of the prescribing practitioner's professional practice.
For purposes of this section and section 20-633c of the general statutes, as amended by this act, "standing order" means a nonpatient specific prescription for an opioid antagonist that is administered by an intranasal application delivery system or an auto-injection delivery system and approved by the federal Food and Drug Administration.
For purposes of this section and section 20-633c of the general statutes, as amended by this act, "standing order" means, an agreement between a prescribing practitioner and a pharmacist whereby the prescribing practitioner issues a nonpatient specific prescription that enables the pharmacist to dispense an opioid antagonist that is administered by an intranasal application delivery system or an auto-injection delivery system and approved by the federal Food and Drug Administration.
(2) A person who is licensed as a pharmacist under part II of this chapter may dispense, in good faith, an opioid antagonist, as defined in section 17a-714a, that is administered by an intranasal application delivery system or an auto-injection delivery system, pursuant to a standing order issued under section 1 of this act.
(2) A person who is licensed as a pharmacist under part II of this chapter and is certified in accordance with subsection (b) of this section may dispense, in good faith, an opioid antagonist, as defined in section 17a-714a, that is administered by an intranasal application delivery system or an auto-injection delivery system, pursuant to a standing order issued under section 1 of this act.
2 October 1, 2017 20-633c Statement of Purpose:
2 October 1, 2017 20-633c Statement of Legislative Commissioners:
To allow pharmacists to dispense opioid antagonists pursuant to a standing order issued by a prescribing practitioner.
In Section 2(a)(2), "and is certified in accordance with subsection (b) of this section" was inserted after "chapter" for consistency with other provisions of the section.
[Proposed deletions are enclosed in brackets.
PH Joint Favorable Subst.
Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.] Co-Sponsors:
SEN.
KENNEDY, 12th Dist.
S.B.
552
⬇ Download PDF
View plain text versions (3)
  • R02 html
  • R01 html
  • R00 Current html

Action History

  1. MOVED TO FOOT OF CAL., SENATE

  2. FILE NO. 611

  3. SENATE CALENDAR NUMBER 332

  4. FAV. RPT., TAB. FOR CAL., SEN.

  5. RPTD. OUT OF LCO

  6. REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 04/12/17

  7. FILED WITH LCO

  8. Joint Favorable Substitute

  9. Vote to Hold until next meeting

  10. REF. TO JOINT COMM. ON Public Health

  11. DRAFTED BY COMMITTEE

  12. Vote to Draft

  13. PUBLIC HEARING 0210

  14. Reserved for Subject Matter Public Hearing

  15. REF. TO JOINT COMM. ON Public Health

Sponsors

  • Ted' b'Kennedy · Primary

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 186 not signed on

Sponsors (1)

  • b'Kennedy, Ted'

Co-sponsors (0)

None.

Not signed on (186)

186 members have not signed on to this bill.

Show all 186 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 552?
SB 552 is sponsored by b'Kennedy, Ted'.
What is the current status of SB 552?
This bill died with 2017 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 552?
Track SB 552 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 552

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 552

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →